Non-Metastatic Neoplasm Clinical Trial
Official title:
Impact of an Intervention Combining Self-care and Hypnosis on the Well-being of Cancer Patients and Their Partners
Verified date | September 2020 |
Source | University of Liege |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Hypnosis-based interventions are starting to be tested in order to improve emotional distress
and fatigue of cancer patients. However, most of these studies only include breast cancer
patients and do no measure long-term effects of such interventions.
Our randomized controlled trial aims to propose to 116 post-treatment cancer patients (all
tumour localisations accepted) an 8-week groupal intervention combining hypnosis and
self-care techniques.
Primary outcomes (emotion regulation, emotional distress, fatigue) and secondary outcomes
(sleep difficulties, fear of recurrence, attentional bias, conjugal communication) will be
investigated at 3 measurement times: before the intervention (T1), 3 months later (T2 - right
after the intervention of the experimental group, and right before the intervention of the
control group) and again 3 months later (T3 - after the intervention of the control group).
Some questionnaires, two relaxation tasks, an attentional task, an actigraph and a smartphone
application will be used to collect data. The indirect impact of the intervention on
participants' partners will also be measured by questionnaires (emotional distress, conjugal
communication).
Data collection has started on March 2017. Our results should bring new knowledge about the
efficacy of an hypnosis-based intervention to improve fatigue and well-being in cancer
patients, which are often under-diagnosed and under-treated, but also about the indirect
efficacy to improve partners' well-being. Those results might contribute to spread this kind
of inexpensive intervention in oncology settings.
Status | Completed |
Enrollment | 104 |
Est. completion date | September 18, 2020 |
Est. primary completion date | October 20, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion criteria are: 1. age 18 years or older; 2. Fluency in French; 3. Having received a diagnosis of non-metastatic cancer (all tumour localisations accepted). 4. Having completed all active treatments for no more than a year (surgery, chemotherapy and radiotherapy). 5. Not being in relapse at the time of inclusion 6. Exhibiting some difficulties as established by responses of at least 4 out of 10 on 1 of the 6 chosen items of the Edmonton Symptom Evaluation Scale (Chang, Hwang, & Feuerman, 2000): physical fatigue, moral fatigue, depression, anxiety, fear of recurrence or ruminations). 7. Wishing to receive help in order to improve the difficulties identified. Exclusion Criteria: Psychiatric disorders, such as dementia, psychosis or delirium, that do not allow to participate in a group intervention or to complete the evaluations |
Country | Name | City | State |
---|---|---|---|
Belgium | University Hospital of Liege | Liege |
Lead Sponsor | Collaborator |
---|---|
University of Liege | FNRS, Jules Bordet Institute, King Baudouin Foundation |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Cancer-Related Fatigue | A sense of tiredness or exhaustion linked with cancer and its treatments, that is not alleviated by sleep. It will be measured with the Multidimensional Fatigue Inventory (MFI-20) and the Insomnia Severity Index (ISI). | T1 (before the intervention), T2 (right after the intervention), T3 (3.5 months follow-up) | |
Primary | Change in emotional distress | Anxiety + Depression, measured with the Hospital Anxiety and Depression Scale (HADS) | T1 (before the intervention), T2 (right after the intervention), T3 (3.5 months follow-up) | |
Secondary | Change in fear of recurrence | Fear that cancer could return. Measured with the Fear of Cancer Recurence Inventory | T1 (before the intervention), T2 (right after the intervention), T3 (3.5 months follow-up) | |
Secondary | Change in emotion regulation | The way people deal with their emotions. Measured with one questionnaire (Cognitive Emotion Regulation Questionnaire) and a smartphone application asking participants about their daily emotion and how they deal with it. The application is used during 9 days at each measurement time. | T1 (before the intervention), T2 (right after the intervention), T3 (3.5 months follow-up) | |
Secondary | Change in attentional bias towards threat | Attentional bias toward emotional information especially negative ones. It is linked with anxiety and will be measured by an computerized task. | T1 (before the intervention), T2 (right after the intervention), T3 (3.5 months follow-up) | |
Secondary | Change in the quality of the conjugal relationship | Communication about cancer and dyadic coping, measured with questionnaires (Couples' Illness Communication Scale ; Dyadic Coping Inventory). The two partners will complete these questionnaires. | T1 (before the intervention), T2 (right after the intervention), T3 (3.5 months follow-up) | |
Secondary | Change in partners' well-being | Anxiety and depression of the partners, measured with the HADS. | - Couples' Illness Communication Scale (CICS) (Arden-Close et al., 2010) Dyadic Coping Inventory (DCI) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT05943301 -
Study of the Impact of Non-pharmacological Techniques on Cognitive Complaints in Cancer Patients
|
N/A | |
Recruiting |
NCT01280825 -
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
|